Univariate Cox proportional hazard model for overall survival
| Variable . | HR (95% CI) . | P . |
|---|---|---|
| Age (above vs below median) | 1.8 (0.7-5.0) | .25 |
| CD4 count (<100 vs ≥100) | 0.5 (0.2-1.4) | .18 |
| HIV VL (<100 vs ≥100) | 1.3 (0.3-5.3) | .70 |
| Concurrent KS | 1.8 (0.6-5.7) | .30 |
| Concurrent T1 KS | 3.0 (1.1-8.4) | .035 |
| T1 KS without PEL | 1.5 (0.6-4.3) | .40 |
| Concurrent PEL | 5.4 (1.8-16.8) | .003 |
| KSHV VL, log10 copies/106 PBMCs (above vs below median) | 1.1 (0.4-3.2) | .85 |
| Cytokines (above vs below median), pg/mL | ||
| IFN-γ | 0.7 (0.3-1.9) | .50 |
| IL-10 | 0.8 (0.3-2.1) | .60 |
| IL-12 | 1.1 (0.4-3.0) | .86 |
| IL-13 | 1.0 (0.4-2.9) | .93 |
| IL-1β | 0.7 (0.3-2.0) | .52 |
| IL-2 | 1.5 (0.5-4.3) | .41 |
| IL-4 | 1.4 (0.5-4.0) | .51 |
| IL-6 | 2.1 (0.7-6.2) | .17 |
| IL-8 | 1.1 (0.4-3.1) | .85 |
| TNF-α | 0.9 (0.3-2.5) | .83 |
| Variable . | HR (95% CI) . | P . |
|---|---|---|
| Age (above vs below median) | 1.8 (0.7-5.0) | .25 |
| CD4 count (<100 vs ≥100) | 0.5 (0.2-1.4) | .18 |
| HIV VL (<100 vs ≥100) | 1.3 (0.3-5.3) | .70 |
| Concurrent KS | 1.8 (0.6-5.7) | .30 |
| Concurrent T1 KS | 3.0 (1.1-8.4) | .035 |
| T1 KS without PEL | 1.5 (0.6-4.3) | .40 |
| Concurrent PEL | 5.4 (1.8-16.8) | .003 |
| KSHV VL, log10 copies/106 PBMCs (above vs below median) | 1.1 (0.4-3.2) | .85 |
| Cytokines (above vs below median), pg/mL | ||
| IFN-γ | 0.7 (0.3-1.9) | .50 |
| IL-10 | 0.8 (0.3-2.1) | .60 |
| IL-12 | 1.1 (0.4-3.0) | .86 |
| IL-13 | 1.0 (0.4-2.9) | .93 |
| IL-1β | 0.7 (0.3-2.0) | .52 |
| IL-2 | 1.5 (0.5-4.3) | .41 |
| IL-4 | 1.4 (0.5-4.0) | .51 |
| IL-6 | 2.1 (0.7-6.2) | .17 |
| IL-8 | 1.1 (0.4-3.1) | .85 |
| TNF-α | 0.9 (0.3-2.5) | .83 |